For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Madrigal Pharmaceuticals (MDGL – Research Report), Organon ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Haleon plc (Symbol: HLN) entered into oversold territory, hitting an RSI reading of 28.4 ...

Haleon missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales of its ...

Many thought peeling off consumer healthcare arm Haleon would help, too. It certainly helped Haleon, whose shares have climbed nicely, but has it worked for GSK? Not so much. Its shares are down 0 ...

Haleon’s Health Inclusivity Screener analyses digital advertising content for readability and inclusivity metrics. It assesses creative content based on health literacy, accessibility and ...

Haleon's share price increased by 20% since July, mainly driven by strong H1 2024 results and strategic moves, among them, increasing their stake in Tianjin TSKF Pharmaceutical. The upcoming ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...